Use of ambulatory glucose monitoring and analysis of ambulatory glucose profile in clinical practice for diabetes management; a position statement of the Arab Society of Paediatric Endocrinology and diabetes

• Published in: Diabetes research and clinical practice 2021-03, Vol.173, p.108671-108671, Article 108671
• Main Authors: Deeb, Asma, Muammar, Tawfik, Alsaffar, Hussain, Sedaghat, Sara, Al Hassani, Noura, Odeh, Rasha, Alkhayyat, Haya, Al Sinani, Aisha, Attia, Najya, Adhami, Sarah, Elbarbary, Nancy
• Format: Article
• Language: English
• Subjects: Adolescent; ambulatory glucose profile (AGP) time in range; Arabs; Blood Glucose - metabolism; Blood Glucose Self-Monitoring - methods; Child; Diabetes Mellitus, Type 1 - therapy; Female; Glycated Hemoglobin A - analysis; haemoglobinopathies; Humans; Intermittent scanning continual glucose monitoring (isCGM); Male; Middle East and North Africa (MENA); Quality of Life - psychology; Ramadan
• ISSN: 0168-8227; 1872-8227
• DOI: 10.1016/j.diabres.2021.108671

•Ambulatory glucose profiles (AGP) facilitate interpretation of CGM data.•In the MENA region, several circumstances complicate glucose monitoring.•E.g., high rates of type 1 diabetes mellitus, haemoglobinopathies, Ramadan fasting.•We present recommendations for effective use of AGP in MENA and beyond.•The aims are higher time in range, lower glucose variability and fewer hypos. Diabetes mellitus imposes a significant burden around the world generally and in the Middle East and North Africa specifically. Glucose monitoring is a cornerstone of diabetes management. Glycated haemoglobin has always been the main metric for assessing glycaemic control, but its use is linked with multiple pitfalls. As an alternative, continuous glucose monitoring is becoming a standard of care in many countries. Intermittent scanning glucose monitoring (isCGM) has acquired a worldwide popularity and has been proven to improve glycaemic control, hypoglycaemia detection and prevention, and quality of life. The most recent International Society of Paediatric and Adolescent Diabetes practice. guidelines recommended its use in young people with diabetes observing Ramadan to ensure safe fasting. At a meeting in Abu Dhabi in November 2019, the Arab Society for Paediatric. Endocrinology and Diabetes brought together a number of regional diabetes experts, patient. representatives and international expert advisors to review the evidence for isCGM and propose. guidelines for its use in the Middle East and North Africa region. In this paper, the authors strongly recommend the use of isCGM for patients in MENA and present general recommendations and compressive specific guidance for physicians and patients, which they believe will also have wider resonance.